-21%

est. 2Y upside i

HealthcareSeries D+

Unlocking the power of biotech with modern software for modern science

Rank

#3194

Sector

Life Sciences Software

Est. Liquidity

~3Y

Data Quality

Data: High

Benchling offers a moderate upside opportunity for a job seeker, driven by its strong competitive moat and aggressive AI integration strategy in a large, growing market.

Last updated: March 10, 2026

Bull (25%)+90%

Benchling's aggressive AI strategy, including partnerships with Anthropic and Lilly TuneLab, drives significant product innovation and market expansion, re-accelerating ARR growth to 35-40% over two years. This leads to an IPO at an estimated $11.59B valuation, rewarding early equity holders.

Base (45%)+25%

Benchling maintains its market leadership and ~27% ARR growth, reaching an estimated ~$508.7M ARR in two years. While the company executes well, valuation multiples compress slightly due to market conditions, resulting in an IPO or acquisition at approximately $7.63B.

Bear (30%)-40%

Growth slows further, potentially closer to the 8.11% reported for 2024 revenue, and increased competition from incumbents like Oracle and Microsoft erodes market share. A prolonged unfavorable IPO market leads to a down round or acquisition at a significantly reduced valuation of approximately $3.66B, substantially impacting common stock value.

Est. time to liquidity~2.5 years

Preference Stack Risk

moderate

Funding Intensity

7%

Investors hold $412M in liquidation preferences, which is 6.75% of the current $6.1B valuation. In an exit at or below this valuation, common stock holders would be behind this preference stack.

Dilution Risk

moderate

As a late-stage company, further funding rounds are possible, which could lead to additional dilution, though likely less impactful than in earlier stages.

Secondary Liquidity

limited

A secondary market valuation of $5.5B and recent activity of $372M in secondary bids/offers/transactions suggests some opportunities for early liquidity, though not a fully active and liquid market.

Engineering — 21 roles

Product & Design — 11 roles

Customer Experience — 7 roles

Marketing — 2 roles

Finance — 1 role

People — 1 role

View all 56 open roles at Benchling →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Benchling's data — designed to show you've done your homework.

  • 1

    “Benchling has made significant strides in AI partnerships (Anthropic, Lilly TuneLab, NVIDIA). How is the company strategically thinking about differentiating its AI offerings from broader AI platforms being developed by tech giants like Google and Microsoft, who are also expanding into life sciences?”

  • 2

    “The company is estimated to have ~$315M ARR with ~27% YoY growth. What are the key strategies to re-accelerate growth towards 35-40% to justify the current high valuation multiple, especially considering the reported 8.11% revenue growth in 2024?”

  • 3

    “Given the Series F funding in late 2021 and the current market conditions that have delayed IPO plans, what is Benchling's updated strategy and timeline for providing liquidity to employees, and how might secondary market activity evolve?”

Community

Valuation Sentiment

Our model estimates -21% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.